CRGX — CARGO Therapeutics Balance Sheet
0.000.00%
- $198.95m
- -$140.76m
Annual balance sheet for CARGO Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 0.041 | 1.87 | 406 | 340 |
Net Total Receivables | 0 | 0.476 | 1.74 | 2.04 |
Prepaid Expenses | ||||
Total Current Assets | 0.184 | 3.93 | 409 | 345 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 3.88 | 5.53 | 38.6 | 34.8 |
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 4.5 | 10.2 | 453 | 414 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 2.45 | 44.1 | 21.2 | 25 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 4.68 | 45.5 | 47.6 | 53.8 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.175 | -35.2 | 405 | 360 |
Total Liabilities & Shareholders' Equity | 4.5 | 10.2 | 453 | 414 |
Total Common Shares Outstanding |